Medicare Fee-For-Service (FFS)
High-priority program
Program level Payment Integrity results
Sponsoring agency: Department of Health and Human Services
View on Federal Program InventoryPROGRAM METRICS
$464,114 M
in FY 2026 outlays, with a
92.7%
payment accuracy rate
-
Improper payment estimates over time
View as:
Chart toggle amounts:Proper paymentsOverpaymentUnderpaymentTechnically improperUnknown
Payment Integrity results
-
FY 2026 improper payment estimates
Chart legend and breakdown
Payment accuracy rate
Improper payment rate
Unknown payment rate
Sampling & estimation methodology details
Sampling timeframe:
07/2024 - 06/2025
Confidence interval:
95% to <100%
Margin of error:
+/-0.5
Causes
The specific gaps were missing orders for hospital outpatient claims; documentation supporting the billed code and coverage criteria for SNF claims; documentation of medical necessity for lab tests-other (Non-Medicare Fee Schedule) claims; and certification or recertification for hospice claims.
| Overpayment root cause | Overpayment amount |
|---|---|
| Amount of overpayments within the agency's control | $0.0 M |
| Amount of overpayments outside the agency's control | $32,679.47 M |
| Amount of overpayments that occurred because the data/information needed to validate payment accuracy prior to making a payment does not exist | $0.0 M |
| Amount of overpayments that occurred because of an inability to access the data/information needed to validate payment accuracy prior to making a payment | $0.0 M |
| Amount of overpayments that occurred because of a failure to access data/information needed to validate payment accuracy prior to making a payment | $32,679.47 M |
| Underpayment root cause | Underpayment amount |
|---|---|
| Amount of underpayments | $1,277.44 M |
| The amount of underpayments that occurred because the data/information needed to validate payment accuracy prior to making a payment does not exist | $0.0 M |
| The amount of underpayments that occurred because of an inability to access the data/information needed to validate payment accuracy prior to making a payment | $0.0 M |
| The amount of underpayments that occurred because of a failure to access data/information needed to validate payment accuracy prior to making a payment | $1,277.44 M |
| The amount of improper payments that were paid to the right recipient for the correct amount but were considered technically improper because of failure to follow statute or regulation | $0.0 M |
| The amount that could either be proper or improper but the agency is unable to determine whether it was proper or improper as a result of insufficient or lack of documentation | $0.0 M |
Prevention
future improper payments, HHS is implementing corrective actions including,
provider education, automated system edits, enhanced prior authorization,
medical reviews, and predictive data analytics to reduce and prevent improper
payments. In FY 2026, significant efforts were undertaken to safeguard the
Medicare trust fund for Part A inpatient prospective payment system claims.
MACs initiated inpatient short stay patient status reviews for acute care
inpatient hospital prospective payment system claims, directly targeting
improper payments and ensuring only medically necessary short stay
admissions were reimbursed. In FY 2026, HHS launched the five-year
Ambulatory Surgical Center Prior Authorization demonstration in 10 states to
verify compliance with coverage, coding, and payment rules before services
are rendered and claims are paid to prevent improper payments. Additionally,
HHS expanded prior authorization for certain DMEPOS items, adding 7
HCPCS codes in April 2026 as well as 8 HCPCS that are pending
implementation in October 2026, while continuing existing required and
voluntary prior authorization for select DMEPOS items and accessories,
including orthoses, wheelchairs, power mobility devices and accessories,
pressure reducing support surfaces, and prosthetics. In FY 2026 HHS also
expanded the Review Choice Demonstration for Inpatient Rehabilitation
Facility (IRF) services to Texas and California, effective March 2, 2026, and
May 1, 2026, respectively, while continuing demonstration operations in Alabama and Pennsylvania. HHS continued the operation of the Repetitive,
Scheduled Non-Emergent Ambulance Transport (RSNAT) Prior Authorization
Model nationwide, and the Review Choice Demonstration for Home Health
Services in Illinois, Ohio, North Carolina, Florida, Texas, and Oklahoma.
HHS continues to prioritize and implement effective corrective
actions and mitigation strategies that reduce improper payments and unknown
payments agency-wide. The actions taken and planned to address the root
causes of the improper payment rate are proportional to the associated amount
and address the root causes of the improper payments. For example, in FY
2026, the primary drivers of the improper payment rate are Skilled Nursing
Facility (SNF), Hospital Outpatient, Laboratory Tests, and Hospice claims. To
drive down the improper payment rate, HHS continues nationwide prior
authorization for certain hospital outpatient services, including Blepharoplasty,
Botulinum Toxin Injections, Panniculectomy, Rhinoplasty, Vein Ablation,
Implanted Spinal Neurostimulators, Cervical Fusion with Disc Removal, and
Facet Joint Interventions claims. Medicare review contractors also continue to
identify and prevent improper payments by conducting targeted medical review
and education. While some reviews are provider-focused, others target
services with error-prone claims, such as SNF, Hospital Outpatient, Laboratory
Tests, and Hospice claims. Medicare review contractors continue to identify
and prevent improper payments due to documentation errors in error-prone
claim types, including SNF and hospital outpatient. HHS will continue to develop and prioritize additional CAPs in FY 2027 based on the FY 2028
improper payment rate data. HHS has also strengthened oversight in several
high-risk areas. On hospice oversight, HHS suspended 822 hospices for
unusually high live discharge rates, holding $133.2 million in payments as of
September 10, 2026. HHS also expanded enhanced oversight through the
Provisional Period of Enhanced Oversight (PPEO) to six states; PPEO has
resulted in revocation of 715 Medicare enrollments based on medical review
results and affiliations that pose an undue risk of fraud, waste, or abuse. On
laboratory oversight, using advanced analytics and payment controls through
the Fraud Defense Operations Center, HHS held $62.73 million in potentially
improper laboratory Medicare payments in suspense as of the end of RY 2026.
HHS also continued and expanded prior authorization programs across
hospital outpatient, durable medical equipment and supplies, ambulatory
surgical center, inpatient rehabilitation facility, home health, and ambulatory
transport services.
areas that were driving the error rate. Based on the error rate data, HHS will
develop corrective action plans to drive down the error rate. In FY 2026, three
key CAPs targeted the top drivers of improper payments: expanded hospice
oversight to curb high live discharge rates and risky enrollments, strengthened
laboratory oversight through advanced fraud analytics, and broadened prior
authorization across several high-risk service categories. These action plans
led to a ninth consecutive year of HHS reporting below the 10% threshold for
compliance.
| Payment type | Mitigation strategies taken | Mitigation strategies planned |
|---|---|---|
| Overpayments | Audit, Automation, Change Process, Predictive Analytics, Training | Audit, Automation, Change Process, Predictive Analytics, Training |
| Underpayments | Audit, Change Process, Training | Audit, Change Process, Training |
| Eligibility element/information needed | Description of the eligbility element/information |
|---|---|
| Contractor or Provider Status | Status or standing of contractor or provider, including recipient eligibility to provide medical services |
| Medical Status | Identifies whether a person is sick/healthy |
Additional information
Reduction target
7.22 %A tolerable rate has not yet been established for this program.
This rate will be identified once the methodology is developed. After the
tolerable rate is set, the agency can assess whether it has the internal controls,
human capital, information systems, and other infrastructure needed. These
elements are essential to reducing improper payments and unknown payments
down to the tolerable rate.
To establish and maintain payment integrity internal controls in
HHS included the following program integrity proposals in its FY 2028 Budget
request: •Expanding Beneficiary Liability Protections Under SSA §1879
•Ensure Providers that Violate Medicare Safety Requirements Cannot Quickly
Reenter the Program •Eliminate DMEPOS AO Framework; Move to CMS
Contractors for DME Quality Standards •Prohibit Unsolicited Medicare
Beneficiary Contacts •Share Info on Providers Subject to a Medicare Payment
Suspension with Supplemental Payers •Expand Prior Authorization/Pre-Claim
Review to Medicare FFS Home Health Services
The agency maintains internal controls to detect, prevent, and
recover improper payments. These controls are reported annually in the
Agency Financial Report (AFR). This annual reporting provides transparency
into how well the controls are functioning. In addition to this reporting, the
agency sets annual performance goals tied to improper payment rates. These
goals help drive continued progress in reducing improper payments. For highpriority programs, the agency also reports quarterly on specific corrective
actions through the quarterly scorecard process.